WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2010029352) TREATMENT OF FIBROTIC EYE DISORDERS USING AN MMP2 INHIBITOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2010/029352    International Application No.:    PCT/GB2009/051148
Publication Date: 18.03.2010 International Filing Date: 09.09.2009
IPC:
A61P 27/02 (2006.01), A61P 27/12 (2006.01), A61K 31/00 (2006.01), A61K 31/16 (2006.01), A61K 31/18 (2006.01), A61K 31/404 (2006.01), A61K 31/535 (2006.01)
Applicants: UNIVERSITY OF EAST ANGLIA [GB/GB]; Norwich Norfolk NR4 7TJ (GB) (For All Designated States Except US).
WORMSTONE, Ian Michael [GB/GB]; (GB) (For US Only).
DAWES, Lucy [GB/GB]; (GB) (For US Only).
ELDRED, Julie Ann [GB/GB]; (GB) (For US Only).
EDWARDS, Dylan [GB/GB]; (GB) (For US Only).
HODGKINSON, Lisa [GB/GB]; (GB) (For US Only)
Inventors: WORMSTONE, Ian Michael; (GB).
DAWES, Lucy; (GB).
ELDRED, Julie Ann; (GB).
EDWARDS, Dylan; (GB).
HODGKINSON, Lisa; (GB)
Agent: BROWN, David Leslie; Haseltine Lake Redcliff Quay 120 Redcliff Street Bristol BS1 6HU (GB)
Priority Data:
61/095,554 09.09.2008 US
Title (EN) TREATMENT OF FIBROTIC EYE DISORDERS USING AN MMP2 INHIBITOR
(FR) TRAITEMENT DE TROUBLES FIBROTIQUES DES YEUX À L'AIDE D'UN INHIBITEUR DES MMP2
Abstract: front page image
(EN)Inhibitors of matrix metalloproteinase 2 are used to treat or prevent a fϊbrotic disorder of the posterior capsule of the eye, for example posterior capsule opacification (PCO), or of a tissue or structure of the eye other than the lens or capsular bag.
(FR)La présente invention concerne des inhibiteurs de la métalloprotéinase matricielle 2 qui sont utilisés pour le traitement ou la prévention d'un trouble fibrotique de la capsule postérieure de l'œil, par exemple une opacification de la capsule postérieure (OCP), ou d'un tissu ou d'une structure de l'œil autre que le cristallin ou le sac capsulaire.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)